GL1X · GenesisL1 explorer

MolNFT v1 · #155975 · protein

Structure of sinonovacula constricta ferritin

6LP5: “Structure of sinonovacula constricta ferritin”. X-ray diffraction, 2 ligands (FE, FE2), 11 pockets (best druggability 0.78). MolNFT v1 #155975 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6LP5
Type
protein
Length
1,020 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ferritin
EC
1.16.3.1
UniProt
D2JIV0
Ligands
FE, FE2
Pockets
11 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, D, E, FFerritin (EC 1.16.3.1)protein17074% helix, 1% strandD2JIV0

Ligands and binding sites

  • FE · Fe (III) ion · metal · 12 copies · chains A, B, C, D, E, F
  • FE2 · Fe (II) ion · metal · 2 copies · chains A, F
  • HEZ · Hexane-1,6-diol · additive · 7 copies · chains B, C, D, E, F

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11010.780.9819HEZ
21790.710.8931empty
31420.710.9028HEZ
47640.700.7772empty
51500.520.7922empty

Interfaces

7 interfaces between chains.

  • C–E · 1315 Ų buried · 19 hydrogen bonds · protein-protein
  • D–F · 1310 Ų buried · 20 hydrogen bonds · protein-protein
  • A–B · 1301 Ų buried · 13 hydrogen bonds · protein-protein
  • B–C · 677 Ų buried · 5 hydrogen bonds · protein-protein
  • A–C · 552 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (additive adduct).

Compared structures

  • 6LP5 · Structure of Sinonovacula constricta ferritin · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.